KLF13 |
KLF13, BTEB3, NSLP1: Krueppel-like factor 13 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
2.845 |
Evidence |
|
FXR1 |
FXR1: Fragile X mental retardation syndrome-related protein 1 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
2.845 |
Evidence |
|
POLR2A |
POLR2A: Uncharacterized protein POLR2A |
CCT4 |
CCT4, CCTD, SRB: T-complex protein 1 subunit delta |
2.845 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
2.845 |
Evidence |
|
PTPN11 |
IPI00298347 |
SOS1 |
SOS1: Son of sevenless homolog 1 |
2.845 |
Evidence |
|
YWHAB |
YWHAB: 14-3-3 protein beta/alpha |
SSRP1 |
SSRP1, FACT80: FACT complex subunit SSRP1 |
2.845 |
Evidence |
|
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
2.845 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
2.845 |
Evidence |
|
HBZ |
HBZ, HBZ2: Hemoglobin subunit zeta |
HBG1 |
HBG1: Hemoglobin subunit gamma-1 |
2.845 |
Evidence |
|
FADD |
FADD, MORT1: Protein FADD |
CREBBP |
CREBBP, CBP: CREB-binding protein |
2.842 |
Evidence |
|
CD3D |
CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor |
SOS1 |
SOS1: Son of sevenless homolog 1 |
2.842 |
Evidence |
|
GNB2L1 |
Lung cancer oncogene 7 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
2.842 |
Evidence |
|
EEF1G |
EEF1G, EF1G, PRO1608: Elongation factor 1-gamma |
DCP1A |
DCP1A, SMIF: mRNA-decapping enzyme 1A |
2.842 |
Evidence |
|
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
HLA-DPB1 |
HLA-DPB1: MHC class II lymphocyte antigen beta chain precursor |
2.84 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
SUPT6H |
|
2.837 |
Evidence |
|
XPO1 |
XPO1, CRM1: Exportin-1 |
MSI1 |
MSI1: RNA-binding protein Musashi homolog 1 |
2.832 |
Evidence |
|
SYNJ1 |
SYNJ1, KIAA0910: Synaptojanin-1 |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
2.832 |
Evidence |
|
PGR |
PGR, NR3C3: Progesterone receptor |
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
2.832 |
Evidence |
|
CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
PPARA |
PPARA, NR1C1, PPAR: Peroxisome proliferator-activated receptor alpha |
2.832 |
Evidence |
|
ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
2.832 |
Evidence |
|
F2R |
F2R, CF2R, PAR1, TR: Proteinase-activated receptor 1 precursor |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
2.83 |
Evidence |
|
KRT18 |
KRT18: Uncharacterized protein KRT18 |
FADD |
FADD, MORT1: Protein FADD |
2.83 |
Evidence |
|
CTGF |
CTGF, CCN2, HCS24: Connective tissue growth factor precursor |
KIAA1967 |
KIAA1967, DBC1: Protein KIAA1967 |
2.83 |
Evidence |
|
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
LMAN2 |
LMAN2, C5orf8: Vesicular integral-membrane protein VIP36 precursor |
2.83 |
Evidence |
|
PLEKHA5 |
PLEKHA5, KIAA1686, PEPP2: Pleckstrin homology domain-containing family A member |
CHC1 |
RCC1: RCC1-I (Fragment) |
2.83 |
Evidence |
|